Drug pricing regulator,the National Pharmaceutical Pricing Authority (NPPA),had imposed penalties on pharmaceutical companies that have been found overcharging consumers on the prices of medicines.It was issued under the provisions of the Drug Price Control Order (DPCO). As per DPCO provisions,companies are liable to deposit overcharged amount for these drugs with interest from the date of… Continue reading When pharma cos. don’t pay up penalties
Tag: NPPA
Cancer drugs 87% cheaper after trade margin cap
Government has announced that maximum retail price(MRP) of 390 non-scheduled cancer medicines have been reduced by up to 87% Earlier,National Pharmaceutical Pricing Authority (NPPA) had invoked powers under Drugs (Prices Control) Order, 2013 and brought 42 non-scheduled anti-cancer drugs under price control by capping trade margin at 30%. The trade margin is the difference between… Continue reading Cancer drugs 87% cheaper after trade margin cap
Govt brings 42 non-scheduled cancer drugs under price control
National Pharmaceutical Pricing Authority (NPPA) has invoked powers under Drugs (Prices Control) Order, 2013 and brought 42 non-scheduled anti-cancer drugs under price control.This will cap trade margin at 30%, which would reduce their retail prices by up to 85%.The trade margin is the difference between the price at which the manufacturers sell to trade and… Continue reading Govt brings 42 non-scheduled cancer drugs under price control
Decision likely today to cap retailer margins of 73 drugs
A relief to patients will soon come up as the drug price regulator National Pharmaceutical Pricing Authority (NPPA) is expected to cap trade margins of 73 medicines for cancer and rare diseases.The trade margin is the difference between the price at which the manufacturers sell to trade and the price that patients pay(maximum retail price).… Continue reading Decision likely today to cap retailer margins of 73 drugs
